Oecotrophologie · Facility Management (OEF)
Refine
Year
Publication Type
- Lecture (427)
- Article (347)
- Part of a Book (209)
- Book (113)
- Conference Proceeding (53)
- Contribution to a Periodical (30)
- Report (20)
- Participation in a Norm (DIN, RFC etc.) (9)
- Master's Thesis (7)
- Working Paper (7)
- Bachelor Thesis (5)
- Course Material (1)
- Review (1)
Language
- German (808)
- English (354)
- Multiple languages (63)
- Spanish (4)
Keywords
- Psychologie (8)
- Covid-19 (7)
- plant-based diet (7)
- Abfallwirtschaft (6)
- Psychotherapie (6)
- Infektionsschutz (5)
- Nachhaltigkeit (5)
- Schutzausrüstung (5)
- Ausbildung (4)
- Corporate Real Estate Management (4)
Faculty
- Oecotrophologie · Facility Management (OEF) (1229)
- Center for Real Estate & Organization Dynamics (158)
- iSuN Institut für Nachhaltige Ernährung (93)
- Kompetenzzentrum Humanitäre Hilfe (21)
- Wirtschaft (MSB) (5)
- Bauingenieurwesen (BAU) (3)
- Energie · Gebäude · Umwelt (EGU) (2)
- IBL (2)
- Architektur (MSA) (1)
Non-communicable diseases (NCD) are associated with high costs for healthcare systems. We evaluated changes in total costs, comprising direct and indirect costs, due to a 24-month non-randomized, controlled lifestyle intervention trial with six measurement time points aiming to improve the risk profile for NCDs. Overall, 187 individuals from the general population aged ≥18 years were assigned to either the intervention group (IG; n = 112), receiving a 10-week intensive lifestyle intervention focusing on a healthy, plant-based diet; physical activity; stress management; and community support, followed by a 22-month follow-up phase including monthly seminars, or a control group (CG; n = 75) without intervention. The complete data sets of 118 participants (IG: n = 79; CG: n = 39) were analyzed. At baseline, total costs per person amounted to 67.80 ± 69.17 EUR in the IG and 48.73 ± 54.41 EUR in the CG per week. The reduction in total costs was significantly greater in the IG compared to the CG after 10 weeks (p = 0.012) and 6 months (p = 0.004), whereas direct costs differed significantly after 10 weeks (p = 0.017), 6 months (p = 0.041) and 12 months (p = 0.012) between the groups. The HLCP-2 was able to reduce health-related economic costs, primarily due to the reduction in direct costs.